Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ubiquitin
-mediated proteolysis plays a central role in controlling intracellular levels of essential regulatory molecules such as p53, cyclins, myc, BRCA1, HIF-1alpha, etc. The
Kruppel-like factor 5
(
KLF5
) transcription factor regulates biological processes involved in carcinogenesis, angiogenesis, and smooth muscle cell differentiation. In carcinogenesis,
KLF5
's role has been indicated by frequent genetic deletion as well as functional studies. Here we show that
KLF5
is an unstable protein with a short half-life. Destruction of
KLF5
was prevented by each of the proteasome-specific inhibitors tested but not by an inhibitor for trypsin-like proteases and cysteine proteases or by a lysosome inhibitor in epithelial cells. Furthermore,
KLF5
underwent ubiquitination, and deletion of a 56-amino-acid sequence adjacent to a known transactivation domain of
KLF5
significantly reduced its ubiquitination and degradation. Interestingly, cancer cells appeared to be more active in
KLF5
degradation than untransformed epithelial cells, yet their proteasome activity was not higher. These results suggest that
KLF5
protein is degraded at least in part through ubiquitination-proteasome pathway, which may have become hyperactive for
KLF5
in cancer cells.
...
PMID:Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. 1573 97